Cost-Effectiveness Analysis of the Gonadotropin Treatments HP-hMG and rFSH for Assisted Reproductive Technology in France: A Markov Model Analysis
Crossref DOI link: https://doi.org/10.1007/s40258-017-0361-7
Published Online: 2017-11-09
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Barriere, Paul
Porcu-Buisson, Géraldine
Hamamah, Samir
Funding for this research was provided by:
Ferring SAS France
License valid from 2017-11-09